These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10435065)

  • 1. Inhibin forms in serum from postmenopausal women with ovarian cancers.
    Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
    Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibin and CA125 assays in the detection of ovarian cancer.
    Robertson DM; Cahir N; Burger HG; Mamers P; McCloud PI; Pettersson K; McGuckin M
    Clin Chem; 1999 May; 45(5):651-8. PubMed ID: 10222351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibins/activins as diagnostic markers for ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
    Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma.
    Robertson DM; Cahir N; Findlay JK; Burger HG; Groome N
    J Clin Endocrinol Metab; 1997 Mar; 82(3):889-96. PubMed ID: 9062502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors.
    Ala-Fossi SL; Mäenpää J; Bläuer M; Tuohimaa P; Punnonen R
    Eur J Endocrinol; 2000 Apr; 142(4):334-9. PubMed ID: 10754473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibin and ovarian cancer].
    Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
    Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.
    Rey RA; Lhommé C; Marcillac I; Lahlou N; Duvillard P; Josso N; Bidart JM
    Am J Obstet Gynecol; 1996 Mar; 174(3):958-65. PubMed ID: 8633676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
    Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
    BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin concentrations in mares with granulosa cell tumors.
    Bailey MT; Troedsson MH; Wheato JE
    Theriogenology; 2002 Apr; 57(7):1885-95. PubMed ID: 12041692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
    Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin as a marker for ovarian cancer.
    Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS
    Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer.
    Phocas I; Sarandakou A; Sikiotis K; Rizos D; Kalambokis D; Zourlas PA
    Anticancer Res; 1996; 16(6B):3827-31. PubMed ID: 9042265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of inhibin in granulosa cell tumors of the ovary.
    Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
    Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
    Markova D; Milchev N; Batashki I; Uchikov A
    Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibins and ovarian cancer.
    Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin as a marker for granulosa cell tumor.
    Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M
    Acta Obstet Gynecol Scand Suppl; 1992; 155():61-5. PubMed ID: 1502891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.